What is Nu Skin Enterprises Inc?
, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide.
NUS · Verdict
Moderate reward · moderate risk
NUS stands out on valuation and balance sheet, but watch the growth signal.
Based on 88% data coverage
NUS · Verdict
P/E 8.6× · PEG 2.35
Interest covered 6.5×
Rev -12.6% CAGR · earnings +15.2%
Model-based scoring. For information only — not financial advice.
, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa, ageLOC LumiSpa iO, and Nu Skin RenuSpa iO; ageLOC TruFace and ageLOC LumiSpa cleansers and devices; Prysm iO, a data-enabled wellness device; and Nutricentials beauty and Beauty Focus wellness brands. The company is listed on the NYSE in USA, operating in the Consumer Defensive sector, with a market capitalisation of 476.78M, and a P/E ratio of 4.5x.
The scoring profile indicates limited reward potential at this time, with valuation and momentum offering the most support. Risk indicators are moderate, consistent with typical market exposure.
For informational purposes only. Not financial advice.